ReviewJournal of cellular and molecular medicine2008
Engineering tissue from human embryonic stem cells.
Review in Journal of cellular and molecular medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine.Annals of biomedical engineering · 2023Review
- Multi-parametric cell profiling with a CMOS quad-modality cellular interfacing array for label-free fully automated drug screening.Lab on a chip · 2018Article
- Static Magnetic Field Effect on Cell Alignment, Growth, and Differentiation in Human Cord-Derived Mesenchymal Stem Cells.Cellular and molecular bioengineering · 2017Article
- Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation.Journal of visualized experiments : JoVE · 2017Article
- Integrated live imaging and molecular profiling of embryoid bodies reveals a synchronized progression of early differentiation.Scientific reports · 2016Article
- The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.Proteomics · 2015Article
- Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix.World journal of stem cells · 2014Review
- Improving efficiency of human pluripotent stem cell differentiation platforms using an integrated experimental and computational approach.Biotechnology and bioengineering · 2013Article
- Self-assembling peptide scaffolds as innovative platforms for drug and cell delivery systems in cardiac regeneration.Drug delivery and translational research · 2013Article
- Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells.Lab on a chip · 2013Article
- Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells.PloS one · 2011Article
- Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of β-catenin signaling.Lab on a chip · 2010Article
- Progenitor cells for regenerative medicine and consequences of ART and cloning-associated epimutations.Molecular biotechnology · 2010Review
- Directed differentiation of human embryonic stem cells to epidermal progenitors.Methods in molecular biology (Clifton, N.J.) · 2010Article
- Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs.Tissue engineering. Part A · 2010Article
- Three-dimensional epithelial tissues generated from human embryonic stem cells.Tissue engineering. Part A · 2009Article
- Scalable culture and cryopreservation of human embryonic stem cells on microcarriers.Biotechnology progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Recent advances in human embryonic stem cell (hESC) biology now offer an alternative cell source for tissue engineers, as these cells are capable of proliferating indefinitely and differentiating to many clinically relevant cell types. Novel culture methods capable of exerting spatial and temporal control over the stem cell microenvironment allow for more efficient expansion of hESCs, and significant advances have been made toward improving our understanding of the biophysical and biochemical cues that direct stem cell fate choices. Effective production of lineage specific progenitors or terminally differentiated cells enables researchers to incorporate hESC derivatives into engineered tissue constructs. Here, we describe current efforts using hESCs as a cell source for tissue engineering applications, highlighting potential advantages of hESCs over current practices as well as challenges which must be overcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.